the gross margin of resonance has been increasing from 35% in 2012 to 77% this year. overall the operation seem to be working capital heavy when compared to the likes of ingrevia (although its understandable that the size of resonance is too small).
the R&D of the company has been reducing (sad to see).
anyone has any idea on why the inventory has increased in this year, the inventory days.
will be waiting for this year’s AR
Subscribe To Our Free Newsletter |